Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD
Daniel Edmonston(Duke University), Tamara Isakova(Northwestern University), Claudia M. Lora(University of Illinois Chicago), Myles Wolf(Harvard University), Mahboob Rahman(Korea Advanced Institute of Science and Technology), Harold I. Feldman(Center for Clinical Research (United States)), Alan S. Go(Kaiser Permanente), Raymond R. Townsend(University of Pennsylvania), Lawrence J. Appel(Korea Advanced Institute of Science and Technology), Debbie L. Cohen(University of Pennsylvania), James P. Lash(Korea Advanced Institute of Science and Technology), Rupal Mehta(Northwestern University), Michael Pencina(Tufts Medical Center), Panduranga S. Rao, Jiang He(Tulane University), Daniel Wojdyla, Xuan Cai(Northwestern University), John W. Kusek(Korea Advanced Institute of Science and Technology)
Cited by 16
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
General Cardiovascular Risk Profile for Use in Primary Care
|Circulation|2008|7.4k
Heart Disease and Stroke Statistics—2013 Update
|Circulation|2012|5.2k